Strategic Alliance

ExxPharma collaborates with pharmaceutical companies through strategic alliance or joint ventures to develop oral dosage forms that meet predetermined clinical endpoints. The Company utilizes formulation platforms and manufacturing technologies that help rapidly advance the projects to registration and commercialization. The dosage forms may comprise immediate release/modified release tablets, capsules, sachets or pellets, and are applicable to poorly soluble and highly water soluble drug substances as well as high dose or fixed dose combination drug products.

 

The collaboration may involve:

  • Development of a new product

  • Development and sharing of technologies

  • Complementary technologies

  • Complementary resources